ArticleFrontiers in immunology2026
From algorithm to verification: based on network toxicology and machine learning, the immunomodulatory role of IGFBP1/MKI67/C9 in perfluorooctanoic acid-induced osteoarthritis was discovered, and a diagnostic model was constructed.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Perfluorooctanoic acid (PFOA), a widespread persistent environmental contaminant, has been associated with osteoarthritis (OA) onset and progression, though mechanisms remain unclear. This study elucidates PFOA's influence on OA pathogenesis, evaluates its effects on disease progression, and identifies diagnostic biomarkers. Method: Obtain PFOA and OA-related gene expression data from public databases, integrate GSE114007 and GSE89408, and perform batch correction. Differentially expressed genes were identified via limma for GO and KEGG enrichment. Six machine learning algorithms (Lasso, SVM, Boruta, XGBoost, LightGBM, AdaBoost) and WGCNA screened key genes. Expression of candidate genes in OA synovial tissue was verified by qRT-PCR, and a diagnostic nomogram was constructed and evaluated. Immune cell infiltration was analyzed by ssGSEA, and molecular docking studied PFOA binding to target proteins. Result: 15 PFOA-related OA differentially expressed genes were identified. Machine learning and WGCNA determined IGFBP1, MKI67 and C9 as core genes; qRT-PCR verified they were significantly upregulated in OA patients. Enrichment analysis revealed involvement in inflammatory, immune and metabolic processes. Immune infiltration analysis indicated multiple immune cells significantly increased in OA samples; core genes helped inhibit excessive Th17 and B cell responses while enhancing Treg and NKT regulatory activity. Molecular docking showed strong binding of PFOA to the three core proteins (binding energies: -6.0, -8.5, -7.5 kcal/mol). The nomogram achieved AUC of 0.903 in training set and 0.939 in external validation set (GSE51588). Conclusion: PFOA exposure may be associated with OA immune microenvironment alterations, potentially involving dysregulation of IGFBP1, MKI67 and C9, contributing to inflammation and cartilage degradation. These three genes are promising diagnostic biomarkers for OA, providing new insights into environmental pollutant involvement in OA pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.